戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and some cases are associated with preceding Campylobacter jejuni infection.
2 eas two had serological evidence of a recent Campylobacter jejuni infection.
3 en described with Haemophilus influenzae and Campylobacter jejuni infection.
4 crobial agents commonly used to treat severe Campylobacter jejuni infection.
5 y acute paralysis, is frequently preceded by Campylobacter jejuni infection.
6 th Guillain-Barre syndrome have had a recent Campylobacter jejuni infection, and axonal forms of the
7                           The recognition of Campylobacter jejuni infection as a frequent antecedent
8                   Extensively drug-resistant Campylobacter jejuni infections cannot be treated with a
9                                   Antecedent Campylobacter jejuni infection, detected by serologic te
10 aphical region, clinical variants, preceding Campylobacter jejuni infection, electrophysiological sub
11 d States, and Hawaii has the highest rate of Campylobacter jejuni infections in the nation.
12                                              Campylobacter jejuni infection is a leading cause of bac
13 re conflicting data about whether antecedent Campylobacter jejuni infection is associated with "axona
14                                      A human Campylobacter jejuni infection model provided controlled
15      For example, in patients with preceding Campylobacter jejuni infection, molecular mimicry causes
16                      In 1998, an outbreak of Campylobacter jejuni infections occurred in Kansas among
17                                              Campylobacter jejuni infection of mice initiated by intr
18                                              Campylobacter jejuni infection often results in bloody,
19   Guillain-Barre syndrome is often caused by Campylobacter jejuni infection that has induced antibodi